What are the research differences in Reta and Tirza?
Retatrutide (Reta) targets three receptors: GIP, GLP-1, and glucagon. Tirzepatide (Tirza) targets GIP and GLP-1. That added glucagon activity makes retatrutide's metabolic profile different, but more receptors do not by themselves prove greater benefit or safety. Tirzepatide has an established clinical evidence base and is an ingredient in FDA-approved prescription medicines; retatrutide remains investigational. Findings from separate trials are not a direct head-to-head comparison and do not establish the safety or effectiveness of research products sold here.
Published Certificates of Analysis appear in Lab Results and on the applicable product record. Products may be offered before results are posted; a missing report is shown clearly.
Match the lot or batch identifier on the product record and label to the lot shown on the certificate. Do not assume a certificate applies to a different batch.
RESEARCH USE
What does research use only mean here?
The store presents products for research purposes only and does not provide human-use, dosing, administration, diagnostic, or therapeutic guidance. The current Research Use Policy contains the controlling store disclosure.
Product-specific storage information appears on the product record when supplied. Solo Lab does not infer missing storage or stability conditions.
CHECKOUT
Can I place an order right now?
Available, published products can be ordered when store setup is complete. Choose Cash App or Zelle at checkout, review the full total, and place your order. Payment is sent separately; fulfillment begins after Solo Lab verifies receipt.
SUPPORT
I have a question about a product record.
Use the Contact page to ask about documentation, product information, or store policies before ordering.